On pharmacodynamics of platelet aggregation depressant cilostazol in hemodialysis patient.
YOSHINOBU OKURA
openalex +2 more sources
Hemorrhage Risk Associated with Anticoagulant and Antiplatelet Drug Combinations: Insights from the USFDA Adverse Event Reporting System. [PDF]
Sridharan K, Sivaramakrishnan G.
europepmc +1 more source
Prognostic factors in aneurysmal subarachnoid hemorrhage during the clazosentan era: a multicenter study using multivariate analyses and machine learning model. [PDF]
Muraoka S +12 more
europepmc +1 more source
Effects of cilostazol for in-stent restenosis after carotid artery stenting: a meta-analysis. [PDF]
Sun J +6 more
europepmc +1 more source
Phosphodiesterase inhibitors as emerging therapeutics for skeletal disorders: A comprehensive review of mechanisms and repurposing potential. [PDF]
Ursachi VC, Horak J, Fafilek B.
europepmc +1 more source
Exploring Plasma Proteome Thermal Stability in Peripheral Arterial Disease: Biophysical Findings Under Cilostazol Therapy. [PDF]
Szabó D, Benkő L, Lőrinczy D.
europepmc +1 more source
Special Issue: "Molecular Diagnosis and Treatments of Diabetes Mellitus". [PDF]
Boldeanu MV.
europepmc +1 more source

